Yüklüyor......
Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?
Existing drugs that have been used in clinical practice for other purposes can prove useful for reutilization, since much of the safety profile and pharmacokinetics have been completed. Therefore, the drugs can enter clinical practice for a variety of causes with less regulatory burden. Metformin ma...
Kaydedildi:
| Yayımlandı: | Am J Physiol Renal Physiol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Physiological Society
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5899225/ https://ncbi.nlm.nih.gov/pubmed/29117997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00443.2017 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|